Based upon the evidence, leflunomide and consequently teriflunomide are candidates for personalized dosing for use in RA. The small unbound fraction of teriflunomide within the blood makes ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

0001) and predominantly men (49.3% vs 23.2; P <.0001). The risk for severe outcomes was elevated with glucocorticoid, mycophenolate derivative, rituximab, leflunomide, sulfasalazine, and JAK inhibitor ...

We present a case of a woman in her late 40s with rheumatoid arthritis who developed DRESS/HLH overlap syndrome after starting hydroxychloroquine and leflunomide therapy. Despite corticosteroid ...

Personalized Medicine. 2014;11(4):449-461.

Biologic therapy reduces TMJ inflammation in children with juvenile arthritis, according to a new study. Findings show ...

Objective: To evaluate the efficacy and safety of adding sulfasalazine to leflunomide treatment compared with switching to sulfasalazine alone in patients with RA with an inadequate response to ...

leflunomide, hydroxychloroquine, gold salts and others). The proposed nomenclature may provide means to group and distinguish the different types of DMARDs in clinical studies and review articles.

Leflunomide-induced drug reaction eosinophilia systemic symptoms and haemophagocytic lymphohistiocytosis overlap syndrome with rheumatoid arthritis (29 January, 2025) ...

Rheumatoid Arthritis Awareness Day 2025 is observed on February 2. Created in 2013 by the Rheumatoid Patient Foundation, it is to raise awareness around the chronic autoimmune disease. Rheumatoid ...

Among those treated for sarcoidosis in the year following diagnosis, 60% used steroids alone, 13% nonsteroidal ...

aFrancis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA bDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA cDepartment ...